← Open Payments lookup

MOHAMMAD IMTIAZ MUBBASHAR: Open Payments

NPI 1619497823 · PETERSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$348 in 15 payments from 9 companies in 2025. Trend: 2023 $320 · 2024 $835 · 2025 $348

Food & beverage: $348
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.4$118
Vanda Pharmaceuticals Inc.2$56
Takeda Pharmaceuticals U.S.A., Inc.2$49
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$33
Alkermes, Inc.1$22
Teva Pharmaceuticals USA, Inc.1$21
Supernus Pharmaceuticals, Inc.1$18
Neurocrine BioSciences, Inc.1$16
Lundbeck LLC1$16

Products named: COBENFY, FANAPT, TRINTELLIX, CAPLYTA, ARISTADA, UZEDY, Qelbree, INGREZZA.

Industry payments across VA — which companies pay providers there.